SAKAR HEALTHCARE
|
SAKAR HEALTHCARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 5.37 | 6.70 | 8.87 | 6.84 | 6.43 |
| CEPS(Rs) | 13.67 | 14.57 | 14.52 | 12.00 | 11.16 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 118.41 | 91.04 | 74.45 | 63.04 | 54.35 |
| Tax Rate(%) | 26.60 | 24.91 | 19.82 | 19.27 | 21.30 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 25.03 | 24.94 | 22.88 | 23.87 | 23.56 |
| EBIT Margin(%) | 15.33 | 17.21 | 17.03 | 16.60 | 17.46 |
| Pre Tax Margin(%) | 10.37 | 12.74 | 14.76 | 13.97 | 14.73 |
| PAT Margin (%) | 7.61 | 9.57 | 11.84 | 11.28 | 11.60 |
| Cash Profit Margin (%) | 19.38 | 20.80 | 19.38 | 19.78 | 20.13 |
| Performance Ratios | |||||
| ROA(%) | 3.22 | 4.22 | 6.81 | 7.30 | 8.36 |
| ROE(%) | 5.42 | 8.48 | 13.44 | 11.88 | 11.83 |
| ROCE(%) | 7.42 | 8.95 | 12.09 | 13.16 | 14.79 |
| Asset Turnover(x) | 0.42 | 0.44 | 0.58 | 0.65 | 0.72 |
| Sales/Fixed Asset(x) | 0.45 | 0.49 | 0.79 | 1.12 | 1.05 |
| Working Capital/Sales(x) | 12.22 | 93.66 | 39.47 | 208.68 | 11.18 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.20 | 2.03 | 1.27 | 0.89 | 0.95 |
| Receivable days | 51.16 | 49.62 | 37.80 | 39.70 | 36.22 |
| Inventory Days | 51.33 | 40.48 | 42.53 | 51.30 | 48.09 |
| Payable days | 116.77 | 140.43 | 123.30 | 90.05 | 46.13 |
| Valuation Parameters | |||||
| PER(x) | 68.64 | 29.94 | 15.24 | 16.54 | 7.77 |
| PCE(x) | 26.95 | 13.77 | 9.31 | 9.43 | 4.47 |
| Price/Book(x) | 3.11 | 2.20 | 1.82 | 1.79 | 0.92 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 5.74 | 3.76 | 2.53 | 2.31 | 1.10 |
| EV/Core EBITDA(x) | 21.17 | 13.21 | 10.29 | 9.21 | 4.22 |
| EV/EBIT(x) | 37.42 | 21.83 | 14.84 | 13.93 | 6.29 |
| EV/CE(x) | 2.58 | 1.71 | 1.21 | 1.23 | 0.79 |
| M Cap / Sales | 5.22 | 2.86 | 1.80 | 1.86 | 0.90 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 14.99 | 4.00 | 35.35 | 14.17 | - |
| Core EBITDA Growth(%) | 9.56 | 20.41 | 32.47 | 10.29 | - |
| EBIT Growth(%) | 2.45 | 5.09 | 38.88 | 8.57 | - |
| PAT Growth(%) | -8.53 | -15.95 | 42.10 | 11.01 | - |
| EPS Growth(%) | -19.92 | -24.44 | 29.65 | 6.34 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.31 | 0.69 | 0.73 | 0.43 | 0.20 |
| Current Ratio(x) | 1.21 | 1.03 | 1.07 | 1.01 | 1.52 |
| Quick Ratio(x) | 0.74 | 0.74 | 0.77 | 0.54 | 0.75 |
| Interest Cover(x) | 3.09 | 3.85 | 7.51 | 6.30 | 6.41 |
| Total Debt/Mcap(x) | 0.10 | 0.31 | 0.40 | 0.24 | 0.22 |
Compare Financial Ratios of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹628.9 Cr | -5.6% | -1.5% | -17.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,838.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,107.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
| CIPLA | ₹120,270.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,077.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹96,553.2 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -5.6% |
-1.5% |
-17.5% |
| SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses
